DOI: 10.12890/2026_007103
A rare presentation of Lyme neuroborreliosis: multifocal cervical and thoracic transverse myelitis-a case report
Authors
rrezarta.ternava@student.uni-pr.edu
Keywords
Transverse myelitis, Lyme disease, neuroborreliosis, multifocal spinal cord lesionsAbstract
Background: Spinal cord involvement in Lyme disease is an uncommon manifestation of neuroborreliosis, with myelitis representing a rare clinical entity. Multifocal transverse, non-contiguous spinal cord involvement remains particularly rare and is insufficiently characterized in the existing literature.
Case report: We report the case of a 40-year-old previously healthy woman who presented with rapidly progressive paraparesis, ascending sensory deficits, and bladder and bowel dysfunction consistent with acute-subacute inflammatory myelopathy. Spinal magnetic resonance imaging (MRI) demonstrated multifocal non-contiguous inflammatory lesions involving the cervical and thoracic spinal cord. Extensive microbiological and serological investigations excluded alternative infectious aetiologies. Brain MRI showed no evidence of demyelinating disease. Despite clinically significant spinal cord inflammation, cerebrospinal fluid (CSF) analysis revealed neither pleocytosis nor elevated protein concentration. However, Borrelia-specific IgM antibodies were detected in both serum and CSF, and a positive Borrelia-specific antibody index (AI 3.07) confirmed intrathecal anti-Borrelia antibody synthesis, establishing the diagnosis of Lyme neuroborreliosis-associated myelitis. The patient subsequently demonstrated marked neurological improvement following targeted treatment with intravenous ceftriaxone combined with corticosteroids and supportive therapy.
Conclusion: This case significantly expands the recognized spectrum of spinal cord involvement in Lyme disease–associated neuroborreliosis by delineating an extremely rare multifocal presentation, thereby emphasizing the critical importance of recognizing atypical manifestations in the diagnostic evaluation of inflammatory myelopathies.
References
- Cardenas-de la Garza JA, De la Cruz-Valadez E, Ocampo-Candiani J, Welsh O. Clinical spectrum of Lyme disease. Eur J Clin Microbiol Infect Dis 2019;38:201–208. doi: 10.1007/s10096-018-3417-1
- Roos KL. Neurologic complications of Lyme disease. Continuum (Minneap Minn). 2021;27:1040–1050. doi: 10.1212/CON.0000000000001015
- Kaiser EA, George DK, Rubenstein MN, Berger JR. Lyme myelopathy: Case report and literature review of a rare but treatable disorder. Mult Scler Relat Disord 2019;29:1-6. doi: 10.1016/j.msard.2018.12.034
- Hieber M, Lambeck J, Rauer S, Bardutzky J. Isolated cervical myelitis in Lyme disease: a rare manifestation of acute neuroborreliosis. Case Rep Neurol 2020;12:276–281. doi: 10.1159/000508404
- Halperin JJ. Nervous system Lyme disease. Infect Dis Clin North Am 2015;29:241–253. doi: 10.1016/j.idc.2015.02.002
- Chohan M, Rana D, Hafez N. Rare case of acute transverse myelitis associated with Lyme neuroborreliosis. IDCases 2022;27:e01422. doi: 10.1016/j.idcr.2022.e01422.
- Rauer S, Kastenbauer S, Hofmann H, Fingerle V, Huppertz HI, Hunfeld KP, et al. Guidelines for diagnosis and treatment in neurology – Lyme neuroborreliosis. GMS Ger Med Sci 2020;18:Doc03. doi: 10.3205/000279
- Gordillo-Pérez G, Solorzano F, Cervantes-Castillo A, Sanchez-Vaca G, García-Ramirez R, Díaz AM, et al. Lyme neuroborreliosis is a severe and frequent neurological disease in Mexico. Arch Med Res 2018;49:399–404. doi: 10.1016/j.arcmed.2018.11.007
- Dessau RB, van Dam AP, Fingerle V, Gray J, Hovius JW, Hunfeld KP, et al. To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a position paper of ESGBOR, the ESCMID study group for Lyme borreliosis. Clin Microbiol Infect 2018;24:118–124.
- Sherifi K, Rexhepi A, Berxholi K, Mehmedi B, Gecaj RM, Hoxha Z, Joachim A, Duscher GG. Crimean-Congo Hemorrhagic Fever Virus and Borrelia burgdorferi sensu lato in Ticks from Kosovo and Albania. Front Vet Sci 2018;5:38. doi: 10.3389/fvets.2018.00038
- National Institute for Health and Care Excellence (NICE). Lyme disease: diagnosis and management [NG95]. 2018. Available from: https://www.nice.org.uk/guidance/ng95